Zydus’s ‘Transparency Failure’ Leads To Block On Indian Perjeta Biosimilar
Delhi Court’s Injunctive Relief Follows Recent Agreement With Dr Reddy’s
“The principles of fairness in procedural conduct, especially in commercial disputes, is crucial,” Delhi’s High Court told Zydus Lifesciences as it agreed to temporarily block the sale of the firm’s recently launched biosimilar to Roche’s Perjeta.
